IBDEI0TW ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30071,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob ALZHEIMER'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,30071,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,30071,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,30072,0)
 ;;=F02.80^^113^1444^41
 ;;^UTILITY(U,$J,358.3,30072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30072,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob ALZHEIMER'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,30072,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,30072,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,30073,0)
 ;;=G31.84^^113^1444^56
 ;;^UTILITY(U,$J,358.3,30073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30073,1,3,0)
 ;;=3^Mild Neurocog D/O d/t ALZHEIMER'S DISEASE
 ;;^UTILITY(U,$J,358.3,30073,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,30073,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,30074,0)
 ;;=F02.81^^113^1444^24
 ;;^UTILITY(U,$J,358.3,30074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30074,1,3,0)
 ;;=3^Major Neurocog D/O d/t ANOTHER MED COND w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,30074,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,30074,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,30075,0)
 ;;=F02.80^^113^1444^25
 ;;^UTILITY(U,$J,358.3,30075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30075,1,3,0)
 ;;=3^Major Neurocog D/O d/t ANOTHER MED COND w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,30075,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,30075,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,30076,0)
 ;;=G31.84^^113^1444^57
 ;;^UTILITY(U,$J,358.3,30076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30076,1,3,0)
 ;;=3^Mild Neurocog D/O d/t ANOTHER MEDICAL CONDITION
 ;;^UTILITY(U,$J,358.3,30076,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,30076,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,30077,0)
 ;;=A81.01^^113^1444^9
 ;;^UTILITY(U,$J,358.3,30077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30077,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Variant
 ;;^UTILITY(U,$J,358.3,30077,1,4,0)
 ;;=4^A81.01
 ;;^UTILITY(U,$J,358.3,30077,2)
 ;;=^336701
 ;;^UTILITY(U,$J,358.3,30078,0)
 ;;=F05.^^113^1444^13
 ;;^UTILITY(U,$J,358.3,30078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30078,1,3,0)
 ;;=3^Delirium d/t Another Medical Condition
 ;;^UTILITY(U,$J,358.3,30078,1,4,0)
 ;;=4^F05.
 ;;^UTILITY(U,$J,358.3,30078,2)
 ;;=^5003052
 ;;^UTILITY(U,$J,358.3,30079,0)
 ;;=F05.^^113^1444^14
 ;;^UTILITY(U,$J,358.3,30079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30079,1,3,0)
 ;;=3^Delirium d/t Multiple Etiologies
 ;;^UTILITY(U,$J,358.3,30079,1,4,0)
 ;;=4^F05.
 ;;^UTILITY(U,$J,358.3,30079,2)
 ;;=^5003052
 ;;^UTILITY(U,$J,358.3,30080,0)
 ;;=R41.0^^113^1444^15
 ;;^UTILITY(U,$J,358.3,30080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30080,1,3,0)
 ;;=3^Delirium,Other Specified
 ;;^UTILITY(U,$J,358.3,30080,1,4,0)
 ;;=4^R41.0
 ;;^UTILITY(U,$J,358.3,30080,2)
 ;;=^5019436
 ;;^UTILITY(U,$J,358.3,30081,0)
 ;;=R41.0^^113^1444^16
 ;;^UTILITY(U,$J,358.3,30081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30081,1,3,0)
 ;;=3^Delirium,Unspec
 ;;^UTILITY(U,$J,358.3,30081,1,4,0)
 ;;=4^R41.0
 ;;^UTILITY(U,$J,358.3,30081,2)
 ;;=^5019436
 ;;^UTILITY(U,$J,358.3,30082,0)
 ;;=G31.09^^113^1444^20
 ;;^UTILITY(U,$J,358.3,30082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30082,1,3,0)
 ;;=3^Frontotemporal Disease
 ;;^UTILITY(U,$J,358.3,30082,1,4,0)
 ;;=4^G31.09
 ;;^UTILITY(U,$J,358.3,30082,2)
 ;;=^329916
 ;;^UTILITY(U,$J,358.3,30083,0)
 ;;=F02.81^^113^1444^36
 ;;^UTILITY(U,$J,358.3,30083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30083,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss FRONTOTEMP LOBAR DEGEN w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,30083,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,30083,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,30084,0)
 ;;=F02.80^^113^1444^37
 ;;^UTILITY(U,$J,358.3,30084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30084,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss FRONTOTEMP LOBAR DEGEN w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,30084,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,30084,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,30085,0)
 ;;=F02.81^^113^1444^42
 ;;^UTILITY(U,$J,358.3,30085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30085,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob FRONTOTEMP LOBAR DEGEN w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,30085,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,30085,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,30086,0)
 ;;=F02.80^^113^1444^43
 ;;^UTILITY(U,$J,358.3,30086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30086,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob FRONTOTEMP LOBAR DEGEN w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,30086,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,30086,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,30087,0)
 ;;=G31.84^^113^1444^58
 ;;^UTILITY(U,$J,358.3,30087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30087,1,3,0)
 ;;=3^Mild Neurocog D/O d/t FRONTOTEMP LOBAR DEGEN
 ;;^UTILITY(U,$J,358.3,30087,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,30087,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,30088,0)
 ;;=F02.81^^113^1444^26
 ;;^UTILITY(U,$J,358.3,30088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30088,1,3,0)
 ;;=3^Major Neurocog D/O d/t HIV INFECTION w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,30088,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,30088,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,30089,0)
 ;;=F02.80^^113^1444^27
 ;;^UTILITY(U,$J,358.3,30089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30089,1,3,0)
 ;;=3^Major Neurocog D/O d/t HIV INFECTION w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,30089,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,30089,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,30090,0)
 ;;=G31.84^^113^1444^59
 ;;^UTILITY(U,$J,358.3,30090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30090,1,3,0)
 ;;=3^Mild Neurocog D/O d/t HIV INFECTION
 ;;^UTILITY(U,$J,358.3,30090,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,30090,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,30091,0)
 ;;=F02.81^^113^1444^28
 ;;^UTILITY(U,$J,358.3,30091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30091,1,3,0)
 ;;=3^Major Neurocog D/O d/t HUNTINGTON'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,30091,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,30091,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,30092,0)
 ;;=F02.80^^113^1444^29
 ;;^UTILITY(U,$J,358.3,30092,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30092,1,3,0)
 ;;=3^Major Neurocog D/O d/t HUNTINGTON'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,30092,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,30092,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,30093,0)
 ;;=G31.84^^113^1444^60
 ;;^UTILITY(U,$J,358.3,30093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30093,1,3,0)
 ;;=3^Mild Neurocog D/O d/t HUNTINGTON'S DISEASE
 ;;^UTILITY(U,$J,358.3,30093,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,30093,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,30094,0)
 ;;=G31.83^^113^1444^23
 ;;^UTILITY(U,$J,358.3,30094,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30094,1,3,0)
 ;;=3^Lewy Body Disease
 ;;^UTILITY(U,$J,358.3,30094,1,4,0)
 ;;=4^G31.83
 ;;^UTILITY(U,$J,358.3,30094,2)
 ;;=^329888
 ;;^UTILITY(U,$J,358.3,30095,0)
 ;;=F02.81^^113^1444^52
 ;;^UTILITY(U,$J,358.3,30095,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30095,1,3,0)
 ;;=3^Major Neurocog D/O w/ Poss LEWY BODIES w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,30095,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,30095,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,30096,0)
 ;;=F02.80^^113^1444^53
 ;;^UTILITY(U,$J,358.3,30096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30096,1,3,0)
 ;;=3^Major Neurocog D/O w/ Poss LEWY BODIES w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,30096,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,30096,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,30097,0)
 ;;=F02.81^^113^1444^54
 ;;^UTILITY(U,$J,358.3,30097,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30097,1,3,0)
 ;;=3^Major Neurocog D/O w/ Prob LEWY BODIES w/ Behav Disturb
